Clinical Trial Update: Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 clinical trial investigating Taxotere (docetaxel) and Doxil (liposomal doxorubicin) for advanced androgen-independent prostate cancer compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Taxotere (docetaxel)

Snippet

Sponsor: University of Louisville | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-09